Cruse Michael 4
4 · Reneo Pharmaceuticals, Inc. · Filed Sep 2, 2022
Insider Transaction Report
Form 4
Cruse Michael
Senior VP-Corporate Operations
Transactions
- Purchase
Common Stock
2022-09-01$3.39/sh+7,500$25,448→ 13,697 total(indirect: By Trust)
Holdings
- 31,758
Common Stock
Footnotes (2)
- [F1]The weighted average purchase price for the transaction was $3.393. The shares were purchased at a range of prices between $3.36 and $3.48. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares purchased at each separate price will be provided.
- [F2]By Michael P. Cruse and Thu Anh Thuy Cruse, Trustees of The Cruse Family Revocable Living Trust.